Chisa Kondo

发表

Association of vitamin D levels and vitamin D-related gene polymorphisms with liver fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease.

A. Tsubota, K. Iwakiri, T. Hatori, 2019, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Liver fibrosis is associated with carotid atherosclerosis in patients with liver biopsy-proven nonalcoholic fatty liver disease

A. Tsubota, K. Iwakiri, H. Sugihara, 2021, Scientific Reports.

Analysis of factors predicting the response to tolvaptan in patients with liver cirrhosis and hepatic edema

A. Tsubota, Y. Matsuzaki, K. Iwakiri, 2018, Journal of gastroenterology and hepatology.

Usefulness of portal vein pressure for predicting the effects of tolvaptan in cirrhotic patients.

A. Tsubota, K. Iwakiri, M. Atsukawa, 2016, World journal of gastroenterology.

Real-world virological efficacy and safety of elbasvir and grazoprevir in patients with chronic hepatitis C virus genotype 1 infection in Japan

T. Masaki, J. Tani, Hirohito Yoneyama, 2018, Journal of Gastroenterology.

Effect of fluvastatin on 24-week telaprevir-based combination therapy for hepatitis C virus genotype 1b-infected chronic hepatitis C

A. Tsubota, Hiroki Yamaguchi, K. Iwakiri, 2014, European journal of gastroenterology & hepatology.

Efficacy of Alfacalcidol on PEG-IFN/ Ribavirin Combination Therapy for Elderly Patients With Chronic Hepatitis C: A Pilot Study

A. Tsubota, K. Iwakiri, C. Sakamoto, 2013, Hepatitis monthly.

Effect of Vitamin D Supplementation on Skeletal Muscle Volume and Strength in Patients with Decompensated Liver Cirrhosis Undergoing Branched Chain Amino Acids Supplementation: A Prospective, Randomized, Controlled Pilot Trial

A. Tsubota, K. Iwakiri, M. Atsukawa, 2021, Nutrients.

Sequential therapy from entecavir to tenofovir alafenamide versus continuous entecavir monotherapy for patients with chronic hepatitis B

A. Morishita, J. Tani, A. Tsubota, 2020, JGH open : an open access journal of gastroenterology and hepatology.

ALBI score predicts morphological changes in esophageal varices following direct-acting antiviral-induced sustained virological response in patients with liver cirrhosis.

K. Matsuura, A. Morishita, J. Tani, 2024, Journal of gastroenterology.

Antifibrotic effect and long‐term outcome of SGLT2 inhibitors in patients with NAFLD complicated by diabetes mellitus

A. Tsubota, K. Iwakiri, H. Sugihara, 2022, Hepatology communications.

Effect of sodium-glucose cotransporter 2 inhibitor in patients with non-alcoholic fatty liver disease and type 2 diabetes mellitus: a propensity score-matched analysis of real-world data

A. Tsubota, K. Iwakiri, H. Sugihara, 2021, Therapeutic advances in endocrinology and metabolism.

Efficacy and safety of ombitasvir/paritaprevir/ritonavir combination therapy for genotype 1b chronic hepatitis C patients complicated with chronic kidney disease

A. Tsubota, Etsuko Iio, Yasuhito Tanaka, 2018, Hepatology research : the official journal of the Japan Society of Hepatology.

Efficacy and safety of ombitasvir/paritaprevir/ritonavir in dialysis patients with genotype 1b chronic hepatitis C

A. Tsubota, Y. Matsuzaki, K. Iwakiri, 2017, Hepatology research : the official journal of the Japan Society of Hepatology.

Daclatasvir and asunaprevir for genotype 1b chronic hepatitis C patients with chronic kidney disease

A. Tsubota, Etsuko Iio, Yasuhito Tanaka, 2017, Hepatology research : the official journal of the Japan Society of Hepatology.

Influencing factors on serum 25-hydroxyvitamin D3 levels in Japanese chronic hepatitis C patients

A. Tsubota, Y. Matsuzaki, K. Iwakiri, 2015, BMC Infectious Diseases.

Association between vitamin D deficiency and pre‐existing resistance‐associated hepatitis C virus NS5A variants

A. Tsubota, K. Iwakiri, Y. Aizawa, 2017, Hepatology research : the official journal of the Japan Society of Hepatology.

Serum 25(OH)D3 levels affect treatment outcomes for telaprevir/peg-interferon/ribavirin combination therapy in genotype 1b chronic hepatitis C.

A. Tsubota, K. Iwakiri, C. Sakamoto, 2014, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Efficacy and safety of oral semaglutide in patients with non‐alcoholic fatty liver disease complicated by type 2 diabetes mellitus: A pilot study

A. Tsubota, K. Iwakiri, Mototsugu Nagao, 2022, JGH open : an open access journal of gastroenterology and hepatology.

Effects of transjugular intrahepatic portosystemic shunt on changes in the small bowel mucosa of cirrhotic patients with portal hypertension

C. Sakamoto, S. Fujimori, M. Atsukawa, 2013, Journal of Gastroenterology.

Effects of sorafenib combined with low-dose interferon therapy for advanced hepatocellular carcinoma: a pilot study

A. Tsubota, K. Iwakiri, M. Atsukawa, 2016, International Journal of Clinical Oncology.

Serum Wisteria floribunda agglutinin‐positive Mac‐2 binding protein more reliably distinguishes liver fibrosis stages in non‐alcoholic fatty liver disease than serum Mac‐2 binding protein

A. Tsubota, K. Iwakiri, H. Hano, 2018, Hepatology research : the official journal of the Japan Society of Hepatology.

The efficacy and safety of glecaprevir plus pibrentasvir in 141 patients with severe renal impairment: a prospective, multicenter study

N. Hotta, A. Tsubota, Yasuhito Tanaka, 2019, Alimentary pharmacology & therapeutics.

Predictive factors for improvement of ascites after transjugular intrahepatic portosystemic shunt in patients with refractory ascites

C. Sakamoto, M. Atsukawa, N. Itokawa, 2014, Hepatology research : the official journal of the Japan Society of Hepatology.

Efficacy and safety of ledipasvir/sofosbuvir for genotype 1b chronic hepatitis C patients with moderate renal impairment

A. Tsubota, Etsuko Iio, Yasuhito Tanaka, 2018, Hepatology International.

Combination of fluvastatin with pegylated interferon/ribavirin therapy reduces viral relapse in chronic hepatitis C infected with HCV genotype 1b

A. Tsubota, C. Sakamoto, Tamaki Kobayashi, 2013, Journal of gastroenterology and hepatology.

YouTubers vs. VTubers: Persuasiveness of human and virtual presenters in promotional videos

H. Sakuma, Y. Hijikata, Chisa Kondo, 2023, Frontiers in Computer Science.